- Home
- STG vs PDSB Comparison
STG vs PDSB Comparison
Compare STG & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- PDSB
- Stock Information
- Founded
- STG 2003
- PDSB 2005
- Country
- STG China
- PDSB United States
- Employees
- STG N/A
- PDSB N/A
- Industry
- STG Other Consumer Services
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- STG Real Estate
- PDSB Health Care
- Exchange
- STG Nasdaq
- PDSB Nasdaq
- Market Cap
- STG 91.6M
- PDSB 58.7M
- IPO Year
- STG 2018
- PDSB N/A
- Fundamental
- Price
- STG $6.51
- PDSB $1.61
- Analyst Decision
- STG
- PDSB Strong Buy
- Analyst Count
- STG 0
- PDSB 3
- Target Price
- STG N/A
- PDSB $14.00
- AVG Volume (30 Days)
- STG 11.0K
- PDSB 226.9K
- Earning Date
- STG 03-21-2025
- PDSB 03-26-2025
- Dividend Yield
- STG N/A
- PDSB N/A
- EPS Growth
- STG N/A
- PDSB N/A
- EPS
- STG 4.57
- PDSB N/A
- Revenue
- STG $292,030,936.00
- PDSB N/A
- Revenue This Year
- STG N/A
- PDSB N/A
- Revenue Next Year
- STG N/A
- PDSB N/A
- P/E Ratio
- STG $1.48
- PDSB N/A
- Revenue Growth
- STG N/A
- PDSB N/A
- 52 Week Low
- STG $4.25
- PDSB $1.30
- 52 Week High
- STG $12.55
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- STG 54.27
- PDSB 47.76
- Support Level
- STG $6.51
- PDSB $1.52
- Resistance Level
- STG $6.78
- PDSB $1.67
- Average True Range (ATR)
- STG 0.26
- PDSB 0.13
- MACD
- STG 0.07
- PDSB 0.04
- Stochastic Oscillator
- STG 65.21
- PDSB 63.89
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.